OSAKA, Japan & CAMBRIDGE, Mass. - Tuesday, 17. January 2023

− Achieved Global Recognition and Top Employer Certification in 22 Countries from Top Employers Institute

− Global Recognition Reinforces Commitment to People and Outstanding People Policies

(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that, for the sixth consecutive year, it was one of only 15 companies to achieve global Top Employer® certification for 2023. In addition to the global certification, Takeda is also recognized as a Top Employer across 22 countries, strengthening its commitment to creating a diverse, equitable and inclusive working environment and an exceptional employee experience.

The Top Employers Institute program certifies organizations based on the participation and results of their HR Best Practices Survey. This survey covers six HR domains consisting of 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, ... Read more »

PORTLAND, Ore. - Wednesday, 18. January 2023

Expensify welcomes George Clooney as the premier global accounting conference's headline speaker in Puglia, Italy

(BUSINESS WIRE)--Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards, and bills, today announced George Clooney as the headline speaker at ExpensiCon. ExpensiCon is the invite-only, all-expenses-paid conference that brings together innovators, thought leaders, disruptors, and transformers of the accounting industry to discuss the future of the ever-changing landscape of finance and accounting.

Clooney, an award-winning actor, businessman, and philanthropist, will join 100 accounting thought leaders at ExpensiCon to share his perspective on building multiple businesses and engaging in projects that encourage social good, aligning with Expensify’s own work in corporate socia ... Read more »

ZUG, Switzerland - Friday, 20. January 2023 AETOSWire

Galderma will share exciting results from the Sculptra® Cheek Wrinkle study showing the long-lasting effectiveness and safety of Sculptra, as well as high aesthetic improvement and patient satisfaction over two yearsi
The company will also present 10 research posters, including positive outcomes from the Alluzience® STAR study. This study shows high patient satisfaction and investigator preference for Alluzience over powder solutions and long duration of effect at six monthsii
Two symposia will build on Galderma’s Holistic Individualized Treatment (HIT™) approach through programs Kiss & Smile™ and Balanced Profile™, and on another new solution offering an innovative long-term treatment approach
(BUSINESS WIRE)--Galderma will be showcasing the latest updates from across its portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Pari ... Read more »